← SynDRA
OMIDENEPAG ISOPROPYL
SynDRA canonical compound SYN0039753 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | PTGER2 |
|---|
| Mechanism of action | prostanoid receptor agonist |
|---|
| Indication | intraocular pressure |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER2 AGONIST
- Prostanoid EP2 receptor agonist
- prostanoid receptor agonist
Drug classes
- Prostaglandin E2 Receptor Agonist
- Prostaglandin E2 Receptor Agonists
ATC classes
- ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Cross-references
Synonyms
- omidenepag
- DE-117
- eybelis
- omlonti
- Omlonti
- G0G0H52U6K
- RefChem:56328
- DTXCID801538072
- Omidenepag isopropyl [USAN]
- Omidenepag isopropyl (JAN)
- OMIDENEPAG ISOPROPYL [JAN]
- Eybelis (TN)
- Omlonti (TN)
- Omidenepag Isopropyl?
- UNII-G0G0H52U6K
- orb1706876
- SCHEMBL15414827
- SCHEMBL29375346
- SCHEMBL30434740
- TQR1222
- GLXC-15225
- EX-A4371
- BDBM50506549
- OMIDENEPAG ISOPROPYL [WHO-DD]
- AKOS040742334
- AT36244
- SB18739
- DA-56446
- MS-29656
- HY-111406
- CS-0040499
- D10966
- T16388
- Omidenepag
- OMLONTI
Look up OMIDENEPAG ISOPROPYL in the interactive SynDRA portal →